These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Discovery and SAR of a novel series of potent, CNS penetrant M4 PAMs based on a non-enolizable ketone core: Challenges in disposition. Wood MR; Noetzel MJ; Tarr JC; Rodriguez AL; Lamsal A; Chang S; Foster JJ; Smith E; Chase P; Hodder PS; Engers DW; Niswender CM; Brandon NJ; Wood MW; Duggan ME; Conn PJ; Bridges TM; Lindsley CW Bioorg Med Chem Lett; 2016 Sep; 26(17):4282-6. PubMed ID: 27476142 [TBL] [Abstract][Full Text] [Related]
14. Optimization of M Melancon BJ; Wood MR; Noetzel MJ; Nance KD; Engelberg EM; Han C; Lamsal A; Chang S; Cho HP; Byers FW; Bubser M; Jones CK; Niswender CM; Wood MW; Engers DW; Wu D; Brandon NJ; Duggan ME; Conn PJ; Bridges TM; Lindsley CW Bioorg Med Chem Lett; 2017 Jun; 27(11):2296-2301. PubMed ID: 28442253 [TBL] [Abstract][Full Text] [Related]
15. Discovery, Optimization, and Biological Characterization of 2,3,6-Trisubstituted Pyridine-Containing M Schubert JW; Harrison ST; Mulhearn J; Gomez R; Tynebor R; Jones K; Bunda J; Hanney B; Wai JM; Cox C; McCauley JA; Sanders JM; Magliaro B; O'Brien J; Pajkovic N; Huszar Agrapides SL; Taylor A; Gotter A; Smith SM; Uslaner J; Browne S; Risso S; Egbertson M ChemMedChem; 2019 May; 14(9):943-951. PubMed ID: 30920765 [TBL] [Abstract][Full Text] [Related]
16. Discovery of a novel, CNS penetrant M Bewley BR; Spearing PK; Weiner RL; Luscombe VB; Zhan X; Chang S; Cho HP; Rodriguez AL; Niswender CM; Conn PJ; Bridges TM; Engers DW; Lindsley CW Bioorg Med Chem Lett; 2017 Sep; 27(18):4274-4279. PubMed ID: 28866269 [TBL] [Abstract][Full Text] [Related]
17. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites. Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966 [TBL] [Abstract][Full Text] [Related]
18. Cognitive enhancement and antipsychotic-like activity following repeated dosing with the selective M Gould RW; Grannan MD; Gunter BW; Ball J; Bubser M; Bridges TM; Wess J; Wood MW; Brandon NJ; Duggan ME; Niswender CM; Lindsley CW; Conn PJ; Jones CK Neuropharmacology; 2018 Jan; 128():492-502. PubMed ID: 28729220 [TBL] [Abstract][Full Text] [Related]